Peptide Therapeutics Near the Sweetest Spots Epsilon09242018-04-01T19:20:09-07:00April 1, 2018|In the News|
Circle Pharma’s work with Pfizer yields new macrocyclic peptides Epsilon09242018-01-19T10:10:53-08:00January 19, 2018|In the News|
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc. Epsilon09242018-01-17T17:54:29-08:00January 17, 2018|Press Releases|
Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer Epsilon09242017-11-20T16:24:26-08:00November 20, 2017|Press Releases|
Practical Medicinal Chemistry with Macrocycles – Design, Synthesis, and Case Studies Epsilon09242017-10-18T17:53:45-07:00October 18, 2017|Publications|
Discovery of potent and orally bioavailable macrocyclic peptide-peptoid hybrid CXCR7 modulators. Epsilon09242017-10-18T10:00:18-07:00October 18, 2017|Publications|
Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets Epsilon09242017-05-29T18:07:39-07:00May 29, 2017|Publications|
Circle Pharma announces expansion of Series A financing and appointment of James C. Lu to its board Epsilon09242017-04-25T17:00:43-07:00April 25, 2017|Press Releases|
Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules Epsilon09242017-01-06T11:00:02-08:00January 6, 2017|Publications|
Circle Pharma announces Series A financing and appoints Walter H. Moos, Ph.D., to its board Epsilon09242016-12-21T10:00:50-08:00December 21, 2016|Press Releases|
